[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20064175L - Heterosyklisk forbindelse - Google Patents

Heterosyklisk forbindelse

Info

Publication number
NO20064175L
NO20064175L NO20064175A NO20064175A NO20064175L NO 20064175 L NO20064175 L NO 20064175L NO 20064175 A NO20064175 A NO 20064175A NO 20064175 A NO20064175 A NO 20064175A NO 20064175 L NO20064175 L NO 20064175L
Authority
NO
Norway
Prior art keywords
ring
heterocyclic compound
alkyl
heterocyclic group
imidazolin
Prior art date
Application number
NO20064175A
Other languages
English (en)
Inventor
Akira Kubo
Tetsu Nakane
Tatsuo Nakajima
Takanori Murakami
Hidetaka Miyoshi
Akihito Ogasawara
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of NO20064175L publication Critical patent/NO20064175L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse er å framskaffe en ny heterosyklisk forbindelse av formelen [I]: hvor R1 er et halogen, nitro, et alkyl, osv.; R2 er hydrogen, et alkyl, osv.; Ring A er 2-okso-4-imidazolin-3,4-diyl, osv.; Ring B er et sykloalkyl, monosyklisk mettet heterosyklisk gruppe; X er CH, N; Y er en enkeltbinding, CO, SO2; Z er O, NH, osv.; og Ring C er et aryl, en heterosyklisk gruppe, eller et farmasøytisk aksepterbart salt av den, som er nyttig som en p38 MAP kinase inhibitor.
NO20064175A 2004-04-28 2006-09-15 Heterosyklisk forbindelse NO20064175L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004133204 2004-04-28
US56608904P 2004-04-29 2004-04-29
JP2005007832 2005-01-14
PCT/JP2005/008564 WO2005105790A1 (en) 2004-04-28 2005-04-28 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
NO20064175L true NO20064175L (no) 2006-12-13

Family

ID=43384198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064175A NO20064175L (no) 2004-04-28 2006-09-15 Heterosyklisk forbindelse

Country Status (12)

Country Link
US (1) US7700771B2 (no)
EP (1) EP1740578B1 (no)
JP (1) JP2007535476A (no)
AT (1) ATE491704T1 (no)
AU (1) AU2005238390C1 (no)
BR (1) BRPI0510335A (no)
CA (1) CA2563042C (no)
DE (1) DE602005025332D1 (no)
MY (1) MY143245A (no)
NO (1) NO20064175L (no)
TW (1) TWI326282B (no)
WO (1) WO2005105790A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113481A1 (en) * 2003-12-17 2010-05-06 Alcon Research, Ltd. Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
MX2007014114A (es) 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
ES2567283T3 (es) 2008-06-03 2016-04-21 Intermune, Inc. Compuestos y métodos para tratar trastornos inflamatorios y fibróticos
DE102009043260A1 (de) 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
DE102009049679A1 (de) 2009-10-19 2011-04-21 Merck Patent Gmbh Pyrazolopyrimidinderivate
DE102010049595A1 (de) 2010-10-26 2012-04-26 Merck Patent Gmbh Chinazolinderivate
JP6211522B2 (ja) * 2011-10-06 2017-10-11 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ ヘテロシクリルピリ（ミ）ジニルピラゾール
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
IL277071B2 (en) 2018-03-08 2024-07-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
WO2023107705A1 (en) 2021-12-10 2023-06-15 Incyte Corporation Bicyclic amines as cdk12 inhibitors
US11993580B1 (en) 2022-12-02 2024-05-28 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
EP1021173A1 (en) * 1997-10-10 2000-07-26 Imperial College Innovations Limited Use of csaid?tm compounds for the management of uterine contractions
CO5170501A1 (es) * 1999-04-14 2002-06-27 Novartis Ag AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
US6492516B1 (en) * 1999-05-14 2002-12-10 Merck & Co., Inc. Compounds having cytokine inhibitory activity
KR20020030791A (ko) 1999-08-12 2002-04-25 버텍스 파마슈티칼스 인코포레이티드 ｃ－ＪＵＮ Ｎ-말단 키나제(ＪＮＫ) 및 기타의 단백질키나제 억제제
EP1289523A1 (en) * 2000-06-01 2003-03-12 Merck & Co., Inc. Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
IL160874A0 (en) * 2001-10-22 2004-08-31 Tanabe Seiyaku Co 4-imidazolin-2-one derivatives
WO2003104223A1 (en) * 2002-06-05 2003-12-18 Pharmacia Corporation Pyrazole-derivatives as p38 kinase inhibitors
JP2005529493A (ja) 2002-06-06 2005-09-29 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 半導体デバイスを有するノンリードクワッドフラットパッケージ
EP2251343A1 (en) * 2003-05-15 2010-11-17 Arqule, Inc. Imidazothiazoles as p38-kinase-inhibitors

Also Published As

Publication number Publication date
US7700771B2 (en) 2010-04-20
TWI326282B (en) 2010-06-21
EP1740578A1 (en) 2007-01-10
CA2563042A1 (en) 2005-11-10
AU2005238390C1 (en) 2009-06-25
EP1740578B1 (en) 2010-12-15
CA2563042C (en) 2010-04-27
ATE491704T1 (de) 2011-01-15
AU2005238390B2 (en) 2009-01-08
BRPI0510335A (pt) 2007-10-23
DE602005025332D1 (de) 2011-01-27
US20070185326A1 (en) 2007-08-09
TW200536843A (en) 2005-11-16
JP2007535476A (ja) 2007-12-06
AU2005238390A1 (en) 2005-11-10
MY143245A (en) 2011-04-15
WO2005105790A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
NO20064175L (no) Heterosyklisk forbindelse
TW200611907A (en) Fused heterocyclic compound
TW200740820A (en) Fused heterocyclic derivatives and use thereof
TW200633991A (en) Chemical compounds
JO2791B1 (en) Acid secretion inhibitor
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
EA200870358A1 (ru) 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1
NO20080761L (no) Acykliske Ikur inhibitorer
ATE508747T1 (de) C-kit kinase-hemmer
AR053662A1 (es) Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
EA200200446A1 (ru) НОВЫЕ α-АМИНОКИСЛОТНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
MA28685B1 (fr) Derives de la quinazolinone, antagonistes de la vanilloide
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
AR055666A1 (es) Inhibidores inntr
ATE553077T1 (de) Peptidaseinhibitoren
ATE519818T1 (de) Reversibel thermochrome zusammensetzung
NO20052023L (no) Kalsium aktivert K kanal apner med hoy konduktans
TW200616997A (en) The preparation method for 6-substituted-1-methyl-1h-benzoimidazol derivatives and their preparation imtermediates
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application